United Kingdom

Xenetic Biosciences Inc (XBIO.OQ)

XBIO.OQ on NASDAQ Stock Exchange Capital Market

20 Aug 2018
Change (% chg)

$-0.11 (-3.69%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Xenetic Biosciences qtrly ‍loss per share $0.26​
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Xenetic Biosciences Inc -:Xenetic Biosciences Inc qtrly ‍loss per share $0.26​.Xenetic Biosciences Inc- ‍current cash position is about $8.0 million, sufficient to fund operations through Q2 of 2018​‍​.  Full Article

Xenetic Biosciences enters into sublicense agreement with subsidiary of Shire Plc
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Xenetic Biosciences :Xenetic Biosciences enters into sublicense agreement related to its Polyxen technology with Baxalta Inc., a wholly-owned subsidiary of Shire Plc.Xenetic Biosciences Inc - ‍Xenetic to receive one-time payment of $7.5 million and single digit royalty payments based upon net sales​.  Full Article

Xenetic Biosciences appoints Jeffrey Eisenberg as CEO
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Xenetic Biosciences Inc -:Xenetic Biosciences appoints Jeffrey F. Eisenberg as chief executive officer.Xenetic Biosciences Inc- ‍Scott Maguire will continue to serve Xenetic during management transition​.  Full Article